Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis
jRCT2080220270Phase 3
- Sponsor
- Abbott Laboratories
- Start
- Jul 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in psoriasis comparing Adalimumab with Placebo (2 arms).
02
Drugs
03
Conditions
psoriasis
Beyond the preview
Go deeper on jRCT2080220270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220270.